Author

Andreas Lundqvist

Karolinska InstitutetORCID 0000-0002-9709-2970Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Hanna van OoijeniD· 2 shared Andreas ParlingiD· 1 shared Arnika Kathleen WagneriD· 1 shared Birte Hell· 1 shared Björn ÖnfeltiD· 1 shared Damien ToulleciD· 1 shared Grace TuryasinguraiD· 1 shared Hanqing ZhangiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Hanna van OoijenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CD4 T cell surface architecture is associated with response to anti-PD-1 therapy in non-small cell lung cancer

Riccardo Cinotti, Ying Yang, Vincent van Hoef, Hanna van Ooijen, Andreas Parling, Mannon Geindreau, neda bigdeli, Mireia Crus De los Santos, Lucas Baldran-Groves, Yiming Yang, Lisa Liu, Maria Johansson, Klas Kärre, Simon Fredriksson, Luigi De Petris, Andreas Lundqvist

The paper shows that CD4 T cell surface protein organization predicts response to anti-PD-1 therapy in NSCLC, outperforming protein abundance alone.

bioRxiv · Oct 30, 2026 · PreprintImmunology

The solid tumor microenvironment changes the hierarchy of CD155 and CD112 receptors, shaping checkpoint blockade outcome

Valentina Carannante, Karl Olofsson, Hanqing Zhang, Niklas Sandström, Jacopo Maria Fontana, Damien Toullec, Grace Turyasingura, Birte Hell, Arnika Kathleen Wagner, Patrick A. Sandoz, Hanna van Ooijen, Andreas Lundqvist, Martin Wiklund, Björn Önfelt

Tumors shape the hierarchy of CD155-CD112 receptors, reducing TIGIT blockade efficacy, while CD226 drives NK infiltration and shows binding plasticity.

bioRxiv · Aug 2, 2026 · PreprintImmunology